Diametric Capital’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,696
Closed -$387K 437
2024
Q1
$387K Buy
+7,696
New +$387K 0.21% 119